Live tape
Top 8, mentions 7d10,485TSLA2,440 mentions▲ +0.06SPCX1,928 mentions▲ +0.08GOOGL1,308 mentions▲ +0.04CRWV1,186 mentions▲ +0.04NVDA1,052 mentions▲ +0.07QQQ1,017 mentions▲ +0.05META787 mentions▲ +0.05NBIS767 mentions▲ +0.07

Equity · Basic Materials

BCPC

NASDAQ

Balchem (BCPC)

$170.43 −0.33% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 19, 2026
Price · Chart
62 sessions
$190 $160 23 Jul 19 Oct

The line runs $161 on 23 July through $170.43 on 19 October, on a scale from $160 to $190. Days the market did not trade hold the previous close, flat.

Market cap $5.4B
P/E (TTM) 33.5
52-week range $142.41 – $183.32
Avg volume 9.0K

as of Oct 19, 2026

Balchem (BCPC) insider trades

SEC Form 4

BCPC has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 12 February 2026.

Date Insider Type Shares Value
04 Dec 2025 van Gunsteren Job Leonard SVP and GM, Specialty Products Sell 6,000 $920K
03 Dec 2025 Fischer David B Sell 8,000 $1.23M
11 Nov 2025 Reid Martin Luther SVP Chief Supply Chain Officer Sell 1,200 $185K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Feb 2026 Bengtsson Carl Martin EVP & Chief Financial Officer Tax withheld 302 $54K
12 Feb 2026 Miyata Hatsuki EVP, CLO, & Secretary Tax withheld 181 $32K
12 Feb 2026 Tignor Michael Brent SVP & Chief HR Officer Tax withheld 165 $29K
12 Feb 2026 Boned Frederic SVP/GM, Human Nutri. & Health Tax withheld 203 $36K
12 Feb 2026 Backus William A. VP & Chief Accounting Officer Tax withheld 70 $12K
12 Feb 2026 Harris Theodore L Chairman, President & CEO Tax withheld 844 $150K
12 Feb 2026 Reid Martin Luther SVP Chief Supply Chain Officer Tax withheld 116 $21K
12 Feb 2026 van Gunsteren Job Leonard SVP and GM, Specialty Products Tax withheld 58 $10K
11 Feb 2026 Fischer David B Director Award 870
11 Feb 2026 Fish Kathleen B Director Award 870
11 Feb 2026 Knutson Daniel E Director Award 870
11 Feb 2026 Rigaud Olivier Director Award 870

Showing the 12 most recent of 43 compensation filings in this window. The figures above count all of them.

Balchem (BCPC) reported financials

SEC EDGAR XBRL SEC EDGAR

Balchem reported revenue of $1.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was $154.8M.

Figure Reported Period
Revenue $1.0B 31 Dec 2025 fiscal year
Net income $154.8M 31 Dec 2025 fiscal year
Diluted EPS $4.75 31 Dec 2025 fiscal year
Total assets $1.7B 30 Jun 2026 at period end
Total equity $1.3B 30 Jun 2026 at period end

Balchem (BCPC) earnings

SEC EDGAR

Balchem last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $1.39; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.39 —
31 Mar 2026 Q1 2026 $1.25 —
31 Dec 2025 FY 2025 $1.21 —
30 Sep 2025 FY 2025 $1.24 —
30 Jun 2025 FY 2025 $1.17 —
31 Mar 2025 Q1 2025 $1.13 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Balchem (BCPC) institutional holders (13F)

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a Balchem position for the quarter ended 30 Jun 2026 — a combined $204.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Held (±25%) +16.7% shares 502,038 $84.8M
Renaissance Technologies Held (±25%) +9.2% shares 193,300 $32.7M
Millennium Management Added +57.3% shares 184,563 $31.2M
Marshall Wace Added +138.1% shares 97,856 $16.5M
AQR Capital Management Held (±25%) −7.3% shares 74,430 $12.6M
Citadel Advisors Added +197.9% shares 61,620 $10.4M
Balyasny Asset Management Held (±25%) +24.2% shares 47,936 $8.1M
Point72 Asset Management Trimmed −72.1% shares 25,803 $4.4M
Bridgewater Associates Held (±25%) −22.5% shares 13,417 $2.3M
D. E. Shaw & Co. Trimmed −77.9% shares 8,897 $1.5M

Balchem (BCPC) fails-to-deliver

SEC CNS data SEC

On 28 Sep 2026, 29 shares of Balchem failed to deliver (about $5K).

Settlement date Shares failed Notional % of shares out
28 Sep 2026 29 $5K <0.001%
22 Sep 2026 14 $2K <0.001%

Congressional trades in Balchem (BCPC)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Balchem is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 17 Sep 2026.

Date Member Type Amount
17 Sep 2026 filed 12 Oct 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
10 Jul 2026 filed 04 Sep 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
09 Apr 2025 filed 14 May 2025 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K

Balchem (BCPC): frequently asked questions

From live data

Have Balchem insiders bought or sold shares recently?

No Balchem insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 12 Feb 2026 (SEC Form 4).

How many institutions hold Balchem?

10 of the 45 institutional funds we track reported a Balchem position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Balchem had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Balchem is dated 28 Sep 2026, when 29 shares failed to deliver.

When did Balchem last report earnings?

Balchem last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $1.39; no next date is announced in SEC filings yet.

What exchange is Balchem listed on?

Balchem trades on NASDAQ under the ticker BCPC.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings